FDA grants real-time liver ablation AI clearance
The U.S. Food and Drug Administration gave De Novo clearance to Techsomed’s BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment for use with its artificial intelligence-powered ablation treatment…
Continue Reading